145 related articles for article (PubMed ID: 23133489)
1. CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads.
Wang LC; Kao CM; Ling P; Su IJ; Chang TM; Chen SH
Clin Dev Immunol; 2012; 2012():580696. PubMed ID: 23133489
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads.
Lin YW; Chang KC; Kao CM; Chang SP; Tung YY; Chen SH
J Virol; 2009 Jul; 83(13):6477-83. PubMed ID: 19386699
[TBL] [Abstract][Full Text] [Related]
3. A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.
Huang KY; Lin JJ; Chiu CH; Yang S; Tsao KC; Huang YC; Lin TY
J Infect Dis; 2015 Sep; 212(5):808-17. PubMed ID: 25712974
[TBL] [Abstract][Full Text] [Related]
4. TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord.
Lin YL; Lu MY; Chuang CF; Kuo Y; Lin HE; Li FA; Wang JR; Hsueh YP; Liao F
Front Immunol; 2020; 11():614743. PubMed ID: 33679702
[TBL] [Abstract][Full Text] [Related]
5. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
7. Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.
Chen IC; Wang SM; Yu CK; Liu CC
Med Microbiol Immunol; 2013 Aug; 202(4):259-65. PubMed ID: 23408291
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues.
Shen FH; Tsai CC; Wang LC; Chang KC; Tung YY; Su IJ; Chen SH
J Gen Virol; 2013 May; 94(Pt 5):1019-1027. PubMed ID: 23288420
[TBL] [Abstract][Full Text] [Related]
9. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
10. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
11. Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses.
Lin YW; Wang LC; Lee CK; Chen SH
Sci Rep; 2018 Aug; 8(1):12184. PubMed ID: 30111869
[TBL] [Abstract][Full Text] [Related]
12. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
14. A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.
Wei R; Yang C; Zeng M; Terry F; Zhu K; Yang C; Altmeyer R; Martin W; De Groot AS; Leng Q
PLoS One; 2012; 7(12):e51957. PubMed ID: 23251663
[TBL] [Abstract][Full Text] [Related]
15. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
16. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection.
Chang GH; Luo YJ; Wu XY; Si BY; Lin L; Zhu QY
Virol J; 2010 May; 7():106. PubMed ID: 20500892
[TBL] [Abstract][Full Text] [Related]
18. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo.
Han JF; Cao RY; Deng YQ; Tian X; Jiang T; Qin ED; Qin CF
Virol J; 2011 Mar; 8():106. PubMed ID: 21385398
[TBL] [Abstract][Full Text] [Related]
19. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
